Bolt Biotherapeutics, Inc. (BOLT) Total Assets by Year
Bolt Biotherapeutics, Inc. closed fiscal year 2025 with $56.7M in total assets, $30.2M in total liabilities and $26.5M in shareholder equity. This represents a decrease of 43.0% from the prior fiscal year. The table below carries 6 fiscal years, from 2020 to 2025, and the quarters Bolt Biotherapeutics, Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
BOLT Balance Sheet by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | FY2510-K | FY2410-K | FY2310-K | FY2210-K | FY2110-K | FY2010-K |
|---|---|---|---|---|---|---|
| Total Assets | $56.7M-43.0% | $99.6M-37.6% | $159.8M-29.9% | $227.8M-26.0% | $307.7M+561.2% | $46.5M |
| Total Liabilities | $30.2M-28.7% | $42.4M-9.8% | $47.0M-16.4% | $56.3M-2.3% | $57.6M-62.0% | $151.5M |
| Total Equity | $26.5M-53.7% | $57.2M-49.3% | $112.7M-34.3% | $171.5M-31.4% | $250.1M+338.3% | -$104.9M |
BOLT Balance Sheet by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'2410-Q | Q1'2410-Q | Q4'2310-K | Q3'2310-Q |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $40.3M-46.6% | $48.0M-44.1% | $56.7M-43.0% | $65.1M-40.5% | $75.5M-39.2% | $85.9M-39.9% | $99.6M-37.6% | $109.3M-37.6% | $124.2M-34.9% | $142.9M-30.7% | $159.8M-29.9% | $175.4M-28.6% |
| Total Liabilities | $27.7M-24.4% | $28.2M-27.8% | $30.2M-28.7% | $33.0M-11.7% | $36.7M-4.3% | $39.1M+0.8% | $42.4M-9.8% | $37.3M-20.8% | $38.3M-21.1% | $38.7M-20.1% | $47.0M-16.4% | $47.1M-17.5% |
| Total Equity | $12.6M-67.5% | $19.8M-57.7% | $26.5M-53.7% | $32.1M-55.4% | $38.8M-54.8% | $46.8M-55.1% | $57.2M-49.3% | $72.0M-43.8% | $85.9M-39.6% | $104.2M-33.9% | $112.7M-34.3% | $128.3M-31.9% |
What total assets means
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders.
More Bolt Biotherapeutics, Inc. financials
Frequently Asked Questions
What was Bolt Biotherapeutics, Inc.'s total assets in fiscal year 2025?
Bolt Biotherapeutics, Inc. closed fiscal year 2025 with $56.7M in total assets, $30.2M in total liabilities and $26.5M in shareholder equity.
How fast is Bolt Biotherapeutics, Inc.'s total assets growing?
Bolt Biotherapeutics, Inc. (BOLT) total assets fell by 43.0% year over year, from $99.6M to $56.7M in fiscal year 2025.
How has Bolt Biotherapeutics, Inc.'s total assets changed over the years?
Across the 6 fiscal years this page covers, Bolt Biotherapeutics, Inc. (BOLT) total assets went from $46.5M in fiscal year 2020 to $56.7M in fiscal year 2025.
What was Bolt Biotherapeutics, Inc.'s total assets in the most recent quarter?
Bolt Biotherapeutics, Inc. (BOLT) reported $40.3M in total assets in Q2 2026. This represents a decrease of 46.6% from the same quarter a year earlier.
What does total assets mean on a financial statement?
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders. This page lists what Bolt Biotherapeutics, Inc. (BOLT) reported on that line in every period on record.